Table 29 Quetiapine for children and adolescents with Anorexia Nervosa
From: Canadian practice guidelines for the treatment of children and adolescents with eating disorders
| Certainty assessment | Impact | Certainty | Importance | ||||||
|---|---|---|---|---|---|---|---|---|---|
| № of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | |||
| Weight, fear of weight gain, side effects | |||||||||
| 1 | Case Report | very serious a | not serious | not serious | not serious | none | Three cases described in which weight increased. | ⨁◯◯◯ VERY LOW | CRITICAL |
| very serious a | not serious | not serious | not serious | none | Fear of weight gain improved. | ⨁◯◯◯ VERY LOW | CRITICAL | ||
| very serious a | not serious | not serious | not serious | none | Side effects - Initial Fatigue, constipation. | ⨁◯◯◯ VERY LOW | CRITICAL | ||